Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 425 for breast cancer

Edit search filters
  1. Efficacy And Safety Of Tislelizumab In Combination With Fruquintinib In Participants With Selected Solid Tumors

    Scottsdale/Phoenix, AZ

  2. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Comparison Of Operation To Monitoring With/Without Endocrine Therapy For Low Risk DCIS

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Test Sacituzumab Govitecan Therapy In Patients With HER2-Negative Breast Cancer And Brain Metastases

    Rochester, MN

  5. Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts

    Jacksonville, FL, Rochester, MN

  6. Oral Tamoxifen Vs. TamGel Vs. Control In Women With Atypical Hyperplasia Or Lobular Carcinoma In Situ

    Rochester, MN

  7. Combination Study Of SV-BR-1-GM In Combination With INCMGA00012 And Retifanlimab

    Jacksonville, FL

  8. A Vaccine (H2NVAC) Before Surgery For The Treatment Of HER2-Expressing Ductal Carcinoma In Situ

    Jacksonville, FL, Rochester, MN

  9. A Study To Compare Conventional Heart Echo Measurements With Newer 2 And 3 Dimensional Measurements Of Mechanical Heart Strain After Trastuzumab Infusion

    Rochester, MN

  10. A Study Of SGN-B7H4V In Advanced Solid Tumors

    Jacksonville, FL

.

Mayo Clinic Footer